| 1.28 0 (0%) | 07-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.63 | 1-year : | 1.73 |
| Resists | First : | 1.39 | Second : | 1.48 |
| Pivot price | 1.31  |
|||
| Supports | First : | 1.25 | Second : | 1.04 |
| MAs | MA(5) : | 1.28 |
MA(20) : | 1.33 |
| MA(100) : | 1.42 |
MA(250) : | 1.74 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 14.5 |
D(3) : | 13 |
| RSI | RSI(14): 32.8 | |||
| 52-week | High : | 2.89 | Low : | 1.25 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SNDL ] has closed above bottom band by 22.1%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.29 - 1.3 | 1.3 - 1.31 |
| Low: | 1.24 - 1.25 | 1.25 - 1.26 |
| Close: | 1.27 - 1.28 | 1.28 - 1.29 |
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
Tue, 21 Jul 2026
SNDL Q2'26 Earnings: revenue estimate is 166.26M USD - TradingView
Wed, 15 Jul 2026
SNDL Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - Quiver Quantitative
Wed, 15 Jul 2026
SNDL Inc. (NASDAQ: SNDL) schedules Q2 2026 results and call - Stock Titan
Wed, 15 Jul 2026
SNDL to Report Second Quarter 2026 Financial Results on July 28, 2026 - Yahoo Finance
Thu, 28 May 2026
SNDL Doesn’t Expect to Close Acquisition of 27 1CM Dispensaries in Ontario - Cannabis Business Times
Wed, 06 May 2026
Should SNDL Stock Be in Your Portfolio Post Q1 Earnings? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 260 (M) |
| Shares Float | 226 (M) |
| Held by Insiders | 4.3 (%) |
| Held by Institutions | 22.1 (%) |
| Shares Short | 1,870 (K) |
| Shares Short P.Month | 2,030 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.95 |
| Profit Margin | -1.2 % |
| Operating Margin | -5.8 % |
| Return on Assets (ttm) | -0.4 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | -4.5 % |
| Gross Profit (p.s.) | 0.97 |
| Sales Per Share | 3.6 |
| EBITDA (p.s.) | 0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 67 (M) |
| Levered Free Cash Flow | 33 (M) |
| PE Ratio | -42.67 |
| PEG Ratio | 0 |
| Price to Book value | 0.43 |
| Price to Sales | 0.35 |
| Price to Cash Flow | 5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|